Scarica l'app Stockscreener
0.36
0.93%
0.0033
Pre-mercato:
.36
Precedente Chiudi:
$0.3567
Aprire:
$0.354
Volume 24 ore:
302.31K
Relative Volume:
0.05
Capitalizzazione di mercato:
$6.18M
Reddito:
$414.60K
Utile/perdita netta:
$-19.21M
Rapporto P/E:
-0.2221
EPS:
-1.6207
Flusso di cassa netto:
$-4.89M
1 W Prestazione:
-0.83%
1M Prestazione:
-18.18%
6M Prestazione:
-68.42%
1 anno Prestazione:
-82.27%
Intervallo 1D:
$0.3531
$0.3814
Intervallo di 1 settimana:
$0.3402
$0.4099
Portata 52W:
$0.162
$2.75
Mangoceuticals Inc Stock (MGRX) Company Profile
Nome
Mangoceuticals Inc
Settore
Industria
Telefono
(833) 626-4679
Indirizzo
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.36 | 6.12M | 414.60K | -19.21M | -4.89M | -1.6207 |
VEEV
Veeva Systems Inc
|
162.17 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.08 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.32 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
86.97 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
68.35 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
Mangoceuticals Inc Borsa (MGRX) Ultime notizie
MGRX Q3 2025 Earnings: EPS Loss of -$0.69 Highlights Ongoing Operational ChallengesPerformance Review - newsline.com
MGRX Price Today: Mangoceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC
MGRX Q3 2025 Earnings: Deepening Losses Amid Pre-Revenue Development StageProfit Announcement - newsline.com
MGRX Technical Analysis & Stock Price Forecast - Intellectia AI
Number of shareholders of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView
MGRX Q3 2025 Earnings: EPS of -$0.69 Reflects Ongoing Investment; Shares Dip 2.56%Subscription Growth Report - The Legal Advocate
MGRX Stock Price, Quote & Chart | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
MGRX Q3 2025 Earnings: Narrowing Losses as Strategic Pivot Gains MomentumEarnings Miss Streak - newsline.com
MGRX Q3 2025 Earnings: EPS Surprises with -$0.69 Loss as Revenue Remains UndisclosedROA Comparison - The Legal Advocate
Mangoceuticals Inc. (MGRX) Holds Near $0.44 After Marginal Uptick — Support and Resistance TightenVolume Profile - Newser
MANGOCEUTICALS, INC. 1Q 2026: Revenue $67.9K, EPS $(0.22) — 10-Q Summary - TradingView
Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash - Stock Titan
MGRX: Net loss narrowed but liquidity and Nasdaq compliance risks persist, requiring urgent funding - TradingView
Mangoceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Mangoceuticals Delays Quarterly Filing After Audit Review - TipRanks
[NT 10-Q] MANGOCEUTICALS, INC. SEC Filing - Stock Titan
MGRX (Mangoceuticals) Q3 loss widens, but stock rallies 7% on positive outlook.Rating Upgrade - Newser
Mangoceuticals stock doubles after Texas lawsuit - MSN
Is Mangoceuticals (MGRX) stock near support |Real-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Mangoceuticals (MGRX) Stock: Market Structure (Buying Pressure) 2026-04-20Collaborative Trading Signals - Newser
Mangoceuticals (MGRX) Stock: Should You Take Exposure (Smart Money Exits) 2026-04-18Top Analyst Buy Signals - Xã Thanh Hà
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Final Week: Can Mangoceuticals Inc expand its profit marginsBull Run & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Support Test: Will Mangoceuticals Inc outperform tech stocksMarket Trend Report & Technical Pattern Based Signals - baoquankhu1.vn
Ideas Watch: Can Mangoceuticals Inc expand into new markets2026 Selloffs & Reliable Volume Spike Alerts - baoquankhu1.vn
Is Mangoceuticals (MGRX) Stock Breaking Out | Price at $0.34, Up 0.30%Corrective Wave - newsline.com
Aug Chart Watch: Does Mangoceuticals Inc have a sustainable dividendQuarterly Trade Review & AI Enhanced Trading Alerts - baoquankhu1.vn
Head to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX) - Defense World
Institution Moves: Will Mangoceuticals Inc benefit from seasonality2026 Big Picture & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Mangoceuticals Inc stock falls amid market weakness - Intellectia AI
Securities.io - Securities.io
Mangoceuticals, Inc. (MGRX) stock price, news, quote and history - Yahoo Finance UK
MGRX Stock Analysis: Mangoceuticals Inc down 2.19% to $0.35, wellness stock outlook - Newser
MGRX: 2025 net loss widened to $20.6M on $456K revenue, with ongoing funding and dilution risks - TradingView
Mangoceuticals, Inc. (MGRX) 2025 Annual Report – Financials, Equity, and Consulting Agreements Overview - Minichart
Mangoceuticals 10-K: Revenue $0.456M, EPS loss $(2.17) - TradingView — Track All Markets
Mangoceuticals (NASDAQ: MGRX) details 1-for-15 reverse split and $100M Solana treasury vision - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Mangoceuticals Delays Annual 10-K Yearly Filing - TipRanks
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Faraday Future Intelligent Electric shares are trading higher by around 55%; here are 20 stocks moving premarket - MSN
Penny Stocks To Watch Today – March 23rd - Defense World
Risks Report: How does Mangoceuticals Inc perform in inflationary periods2026 Patterns & Smart Money Movement Tracker - baoquankhu1.vn
MGRX Mangoceuticals (NASDAQ) pre-market +99.81% Mar 24, 2026: watch heavy volume - Meyka
Mag Mile Capital (OTCQB: MMCP) Surges 365% as CRE Financing Pipeline Expands Across Key Sectors - marketscreener.com
Mangoceuticals (MGRX) Stock Rockets 130% Following CEO’s Substantial Share Award - mexc.com
Mangoceuticals (MGRX) Stock Surges 130% After CEO Lands 500K Share Bonus - MEXC Exchange
Mangoceuticals Inc Azioni (MGRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
3.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):